Cerenome Inc.
Organization details
- Legal name
- Cerenome Inc.
- Former names
- Plus Therapeutics, INC. Cytori Therapeutics, INC. Macropore Inc
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 3841 — Surgical & Medical Instruments & Apparatus
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Houston
- Headquarters state / province
- Texas
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- CNSY
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001095981
- EIN
- 33-0827593
- Wikidata ID
- Q113510380
Board of directors
-
Es-Johansson An Van · DirectorSince 2023
-
Greg Petersen · DirectorSince 2023
-
Howard Clowes · DirectorSince 2023
-
Kyle Guse · DirectorSince 2025
-
Marc H. Hedrick · Director · Chief Executive OfficerSince 2023
-
Richard J. Hawkins · DirectorSince 2023
-
Robert P. Lenk · DirectorSince 2023
-
Ronald Asbury Andrews · DirectorSince 2026
Chief executives
Director election results
Annual meeting of May 14, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
84.4%
-
87.9%
-
87.9%
-
88.1%
-
88.4%
Board connections
3 of this board's directors also sit on 2 other boards. 1 is in the same sector.
-
Savara Inc. Same sectorvia Es-Johansson An Van and Richard J. Hawkins
- via Ronald Asbury Andrews
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 1, 2026 | Ronald Asbury Andrews Director | Option exercise | +921 | — | — |
| Oct 1, 2026 | Kyle Guse Director | Option exercise | +921 | — | — |
| Oct 1, 2026 | Marc H. Hedrick Director, Officer (Chief Executive Officer) | Option exercise | +6,387 | — | — |
| Oct 1, 2026 | Sims Andrew John Hugh MacIntyre Officer (Chief Financial Officer) | Option exercise | +1,533 | — | — |
| Oct 1, 2026 | Richard J. Hawkins Director | Option exercise | +921 | — | — |
| Oct 1, 2026 | Es-Johansson An Van Director | Option exercise | +921 | — | — |
| Oct 1, 2026 | Howard Clowes Director | Option exercise | +921 | — | — |
| Oct 1, 2026 | Marc H. Hedrick Director, Officer (Chief Executive Officer) | Option exercise | +8,066 | — | — |
| Oct 1, 2026 | Sims Andrew John Hugh MacIntyre Officer (Chief Financial Officer) | Option exercise | +1,165 | — | — |
| Oct 1, 2026 | Marc H. Hedrick Director, Officer (Chief Executive Officer) | Option exercise | +1,986 | — | — |
| Oct 1, 2026 | Sims Andrew John Hugh MacIntyre Officer (Chief Financial Officer) | Option exercise | +287 | — | — |
| Jul 1, 2026 | Ronald Asbury Andrews Director | Option exercise | +922 | — | — |
| Jul 1, 2026 | Howard Clowes Director | Option exercise | +922 | — | — |
| Jul 1, 2026 | Kyle Guse Director | Option exercise | +922 | — | — |
| Jul 1, 2026 | Marc H. Hedrick Director, Officer (Chief Executive Officer) | Option exercise | +6,387 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Cerenome Inc.
Who is the CEO of Cerenome Inc.?
Marc H. Hedrick is Cerenome Inc.'s Chief Executive Officer.
How many directors are on Cerenome Inc.'s board?
Cerenome Inc.'s board has 8 directors: Es-Johansson An Van, Greg Petersen, Howard Clowes, Kyle Guse, Marc H. Hedrick, Richard J. Hawkins, Robert P. Lenk and Ronald Asbury Andrews.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="cerenome-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.